EconPapers    
Economics at your fingertips  
 

Efficacy of Phytotherapy in Oral Mucosites Induced by Chemotherapy and Radiotherapy Phytotherapy in OM really work?

Braz José do Nascimento Júnior, Jackson Roberto Guedes da Silva Almeida, Paulo Roberto Ramos and Elba Lúcia Cavalcante de Amorim
Additional contact information
Braz José do Nascimento Júnior: Department of Human Morphology, Federal University of the São Francisco Valley, Brazil
Paulo Roberto Ramos: Departament of Pharmacy, Federal University of the São Francisco Valley, Brazil
Elba Lúcia Cavalcante de Amorim: Department of Pharmacy, Federal University of Pernambuco, Brazil

Global Journal of Pharmacy & Pharmaceutical Sciences, 2018, vol. 6, issue 1, 1-2

Abstract: Oral mucositis (OM) is a complication of cancer therapy. Because of the associated complications, patients with OM go through decreasing doses or until the suspension of chemotherapy treatment or radiotherapy of head and neck until the improvement of the clinical picture, with that, exposing them the progression of the tumor. Current treatments produce limited results and rely on oral cryotherapy using ice, low-power laser exposure and systemic administration of keratinocyte growth factor (Palifermin).The use of medicinal plants and herbal medicine in the treatment of OM is still little used, but with a tendency to expand and accept the pharmaceutical market. We can conclude that phytotherapy is an expanding market and that, although efficient, needs more research and better acceptance of oncologists and other health professionals. Also some mechanisms of action are still not well understood, therefore, studies are needed that evaluate the long-term effects, in addition to standardized clinical protocols that prove efficacy. An efficient natural product in the treatment of OM should have an anti-inflammatory, bactericidal, antioxidant and healing effect on oral mucosa. In this sense, the search for multi-herbs products can be promising, since the plants together can have superior synergistic effects to the isolated species. However, there are few products in the current market with this profile.

Keywords: juniper publishers:Journal of Pharmacy; Global Journal of Pharmacy; Pharmaceutical Sciences; Pharmacy & Pharmaceutical Sciences; pharmaceutical sciences journals; omics online; open access; drug discovery; Clinical Trials; juniper publishers open access journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555676.pdf (application/pdf)
https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555676.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjpps:v:6:y:2018:i:1:p:1-2

DOI: 10.19080/GJPPS.2018.06.555676

Access Statistics for this article

Global Journal of Pharmacy & Pharmaceutical Sciences is currently edited by Sophia Mathis

More articles in Global Journal of Pharmacy & Pharmaceutical Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().

 
Page updated 2025-03-19
Handle: RePEc:adp:jgjpps:v:6:y:2018:i:1:p:1-2